EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Track record

Tools

  • Compare
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›IBEX

IBEX

IBEX Ltd

Next earnings Sep 9, 2026 (after close) · consensus $0.86 EPS, $163M rev

Last earnings -0.8% on 2026-05-06

Buy
$30.08
▲ +3.33%
$30.08▲ +9.46%
over 1Y
L $26.40EODHDH $42.00
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.3%
1W+2.0%
1M-3.3%
3M+13.9%
YTD-17.2%
1Y+9.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
B+
Valuation
Undervalued
Filings
Watch
Buy
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Sell

Revenue grew 9.8% YoY.

The read

Quality fundamentals and an attractive price line up (~98% below fair value) — the rarer case where both the business and the entry look good.

IBEX Ltd shows $558M in FY2025 revenue (+9.8% YoY), a 6.6% net margin, and 27.4% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$443M$493M$523M$509M$558M
Gross profit—————
Operating income$17.0M$20.6M$40.5M$39.4M$46.6M
Net income$13.1M$21.5M$31.6M$33.7M$36.9M
Diluted EPS$0.71$1.15$1.67$1.84$2.36
Net margin3.0%4.4%6.0%6.6%6.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$385M
EV / EBITDA6.0
EV / Sales0.7
EV / FCF14.1
P / FCF14.7
PEG (trailing)1.34
Earnings yield9.2%
FCF yield6.8%

Quality & risk

ROIC (est.)27.4%
Free cash flow$27.3M
Total debt—
Net cash$15.3M
Altman Z-Score4.76 safe
Piotroski F-Score6/7

Capital returns

Buyback yield19.5%
Dividend yield (est.)0.0%
Shareholder yield19.5%
Shares Δ YoY-20.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Other event2026-05-13
  2. 8-K Earnings results2026-05-06
  3. 10-Q Quarterly report2026-05-06
  4. 8-K Earnings results2026-02-05
  5. 10-Q Quarterly report2026-02-05
  6. 8-K Officer / director change2025-12-19
  7. 8-K Officer / director change2025-12-10
  8. 8-K Officer / director change2025-11-24
  9. 10-Q Quarterly report2025-11-06

Recent filings

all on EDGAR ↗
4Period ending 2026-06-112026-06-16open ↗144Filing2026-06-11open ↗4Period ending 2026-05-282026-05-29open ↗144Filing2026-05-28open ↗4Period ending 2026-05-222026-05-27open ↗8-KPeriod ending 2026-05-112026-05-13open ↗4Period ending 2026-05-132026-05-13open ↗4Period ending 2026-05-112026-05-13open ↗144Filing2026-05-13open ↗144Filing2026-05-12open ↗144Filing2026-05-11open ↗10-QPeriod ending 2026-03-312026-05-06open ↗

Quality score

B+
ValueGrowthProfitHealthMom.
ValueA
GrowthB
ProfitabilityB
Financial healthB+
Momentum—
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✓P/E below 25

Fair value est.

$59.66

Undervalued +98% vs price

cheapfair valueexpensive

Modified Graham: EPS $2.36 × (8.5 + 1.5 × 9.7% growth) × 1.10 quality = 25.3× multiple. An estimate, not a price target.

Revenue
$558M
+9.8% YoY
Net margin
6.6%
ROE
27.4%
P/E
12.7

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$558M+9.8%
Net income$36.9M+9.5%
Operating income$46.6M+18.2%
Diluted EPS$2.36+28.3%
Cash & equivalents$15.3M-75.5%
Total assets$273M-7.0%
Total liabilities$139M+8.4%
Stockholders' equity$134M-19.0%
Op.: 8.3%L/E: 1.03x

Frequently asked

Is IBEX Ltd (IBEX) a buy?
IBEX currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. Revenue grew 9.8% YoY.
What is IBEX's fair value?
A Modified-Graham model based on IBEX's SEC fundamentals estimates a fair value of about $59.66. It is an estimate from reported earnings, not a price target.
Is IBEX overvalued or undervalued?
Against a Modified-Graham fair-value estimate, IBEX currently appears undervalued relative to its SEC-grounded earnings power.
What is IBEX Ltd's quality score?
IBEX scores 77.23529411764706/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001720420, latest 10-Q filed 2026-05-06) · EODHD · as of 6/22/2026, 9:48:07 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 6 sales

2026-06-11
Casteel Julie K
Chief Sales/Marketing Officer
Sell3.60K @ $30.61$110K
2026-05-28
McGinnis Patrick
Director
Sell1.03K @ $31.69$32.6K
2026-05-22
Greenwald Taylor C
Chief Financial Officer
Award3.33K
2026-05-22
Greenwald Taylor C
Chief Financial Officer
Sell964.00 @ $32.02$30.9K
2026-05-13
Dechant Robert Thomas
Chief Executive Officer
Sell7.80K @ $30.50$238K
2026-05-12
Dawson Bruce Neil
Chief Sales and CS Officer
Sell15.3K @ $31.12$475K
2026-05-11
Dawson Bruce Neil
Chief Sales and CS Officer
Sell3.13K @ $32.80$103K
2026-03-02
Jones John William
Director
Award2.25K
2026-03-02
Zhuang Mingzhe
Director
Award2.08K
2025-12-02
Ballou-Aares Daniella
Director
Sell500.00 @ $35.01$17.5K
2025-03-13
Ballou-Aares Daniella
Director
Sell5.84K @ $24.22$142K
2025-03-13
Ballou-Aares Daniella
Director
Sell157.00 @ $24.21$3.80K

Earnings history

beat/miss · move
2026-05-06Beat +4.3% est▼ -0.85%8-K ↗
2026-02-05Beat +8.7% est▼ -0.75%8-K ↗
2025-11-06Beat +20.0% est▼ -1.50%8-K ↗
2025-09-11Beat +21.8% est▲ +5.33%8-K ↗
2025-05-08—▲ +1.74%8-K ↗
2025-02-06—▼ -0.67%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
IBEX Limited Q3 2026 Earnings Call SummaryBullish
finance.yahoo.com· 2026-05-07
ibex to Showcase AI-Powered CX Solutions for Utilities at the IUCX Annual Conference 2026Bullish
globenewswire.com· 2026-04-13
IBEX Conference: Management Touts Organic Growth, Margin Gains, and AI-Powered BPO UpsideBullish
finance.yahoo.com· 2026-03-20
Sidoti Events, LLC's March Small-Cap Virtual ConferenceBullish
finance.yahoo.com· 2026-03-18
U.S. Futures Edge Up as Public Holidays Dim TradingBullish
finance.yahoo.com· 2026-02-16
IBEX raises FY26 revenue guidance to $630M as AI leadership, HealthTech growth, and India expansion drive margin gainsBullish
seekingalpha.com· 2026-02-06

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score77 vs 67
Revenue growth9.8% vs 7.1%
Net margin6.6% vs 10.5%
Return on equity27.4% vs 12.3%
P/E12.7 vs 25.5